Aureus
AExcellent

Bristol-Myers Squibb Company(BMY)

A

Financial data as of Dec 31, 2025Declining · Healthcare

FCF Margin26.7%Free Cash Flow / Revenue
Cash Conversion200.7%Operating CF / Net Income
Free Cash Flow$12.8B
Revenue$48.2B
Net Cash-$36.9BNet debt position
Debt / FCF3.7xElevated debt burden
Current Ratio1.26Adequate short-term liquidity
YoY FCF Growth-60.5%5 of 5 quarters positive

How This Grade Was Calculated

Base grade from FCF margin, adjusted by financial health factors

BaseA
→
+0.5Healthy FCF margin with manageable debt (26.7%, 3.7x)
→
-1Significant YoY FCF decline (-60.5%)
→
FinalA

Analysis Summary

Strengths

  • Exceptional FCF margin (26.7%)
  • Excellent cash conversion (201%)

Concerns

  • Net debt position ($36.9B) — 3.7x FCF, manageable
  • Significant YoY FCF decline (-60.5%)

Financial Breakdown

Key financials compared side by side

Margin Composition

FCF Margin26.7%
Net Margin14.6%
Operating CF Margin29.4%
CapEx Ratio2.7%

Balance Sheet Health

Debt, liquidity, and leverage snapshot

Net Cash-$36.9BNet debt position
Debt / FCF3.7xElevated debt burden
Current Ratio1.26Adequate liquidity
Debt / Equity2.55High leverage

Quarterly FCF Trend

-60.5% YoYDeclining (-60.5%)

Free cash flow per quarter

Sector Comparison — Healthcare

FCF Margin ranked against sector peers

View all →

Detailed Metrics

Company NameBristol-Myers Squibb Company
SectorHealthcare
Free Cash Flow$12.8B
Revenue$48.2B
Net Income$7.1B
Operating Cash Flow$14.2B
Capital Expenditure$1.3B
FCF Margin26.7%
Cash Conversion Rate200.7%
Net Margin14.6%
Total Debt$47.1B
Total Cash$10.2B
Net Cash-$36.9B
Current Ratio1.26
Debt / Equity2.55
Debt / FCF3.7x
YoY FCF Growth-60.5%
Positive Quarters5 of 5
Trend DirectionDeclining
Report DateDec 31, 2025
GradeA
Data SourceYahoo Finance